Press Releases
To stay up to date with our development, sign up for a subscription.
2019
2019-04-24 16:45
Participation A shareholder wishing to participate at the meeting must be entered as shareholder in the share register kept by Euroclear Sweden AB on the record date Wednesday 22 May 2019, and must notify the company of their attendance no later than...
2019-04-10 07:30
"The FDA has set clear requirements that are in line with the expectations we had, and they are also possible for us to live up to. Our image of what needs to be done is thus very good," said Christer Ahlberg, CEO of Sedana Medical. Since the...
2019-03-12 07:00
Fourth quarter, October – December 2018 January – December 2018 Significant events during October – December Significant events after the reporting period Please find the full year-end report at: http://www.sedanamedical.com under Investors...
2019-03-08 08:00
"This is very positive news. The interim analysis shows a low standard deviation in the primary variable, the proportion of time with adequate sedation, i.e. the effect of IsoConDa and propofol. This means that we will need to include fewer patients...
2019-03-07 20:00
Sedana Medical invites all interested parties to a webcast conference call, with presentation of the year-end report at. 10.30 CET. Sedana Medical's CEO Christer Ahlberg and CMO Peter Sackey participate in the presentation held in English. Information...
2019-02-20 13:00
One of Sedana Medical´s missions is to improve patient outcomes through medical innovation. Sedana Medical Research Foundation is established to stimulate and support international research in the field of sedation of mechanically ventilated Intensive...
2019-02-12 13:30
A complete Marketing Authorization Application (MAA) for drugs in EU must include a PDCO agreed and approved study plan for children, a so-called PIP (Pediatric Investigation Plan). "It is incredibly satisfying that PDCO has now approved our planned...
2018
2018-12-03 23:00
Press release December 03, 2018. Sedana Medical AB (publ) today publish that in accordance with the resolution of the Annual General Meeting on May 22, 2018, the Chairman of the Board has contacted the company’s three largest shareholders or group...
2018-12-03 17:00
Sedana Medical's Nomination Committee for the 2019 Annual General Meeting consists of: Karl Tobieson is appointed chairman of the Nomination Committee. The Nomination Committee represents 27.2 per cent of all voting rights in the company as of September...
2018-11-22 07:00
Financial Summary July-September Financial Summary January-September Significant events during the period Significant events after the period CEO comments During the third quarter, major steps were taken towards our vision of becoming world leader in...